These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13652949)

  • 1. Metabolites of LSD and ergometrine.
    SLAYTOR M; PENNEFATHER JN; WRIGHT SE
    Experientia; 1959 Mar; 15(3):111. PubMed ID: 13652949
    [No Abstract]   [Full Text] [Related]  

  • 2. THE METABOLITES OF ERGOMETRINE AND LYSERGIC ACID DIETHYLAMIDE IN RAT BILE.
    SLAYTOR MB; WRIGHT SE
    J Med Pharm Chem; 1962 May; 5():483-91. PubMed ID: 14056385
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD 25) in the animal body.
    STOLL A; ROTHLIN E; RUTSCHMANN J; SCHALCH WR
    Experientia; 1955 Oct; 11(10):396-7. PubMed ID: 13277462
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of lysergic acid diethylamide.
    AXELROD J; BRADY RO; WITKOP B; EVARTS EV
    Nature; 1956 Jul; 178(4525):143-4. PubMed ID: 13348650
    [No Abstract]   [Full Text] [Related]  

  • 5. [Distribution of lysergic acid diethylamide in the organism].
    LANZ U; CERLETTI A; ROTHLIN E
    Helv Physiol Pharmacol Acta; 1955; 13(3):207-16. PubMed ID: 13306100
    [No Abstract]   [Full Text] [Related]  

  • 6. The fluorometric determination of lysergic acid diethylamide and ergonovine.
    BOYD ES
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):43-51. PubMed ID: 13545885
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.
    Holohean AM; White FJ; Appel JB
    Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary studies of the metabolism of lysergic acid diethylamide using radioactive carbon-marked molecules.
    BOYD ES; ROTHLIN E; BONNER JF; SLATER IH; HODGE HC
    J Nerv Ment Dis; 1955 Nov; 122(5):470-1. PubMed ID: 13320145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psychophysical correlations. VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline].
    FISCHER R; GEORGI F; WEBER R
    Schweiz Med Wochenschr; 1951 Sep; 81(35):837-40. PubMed ID: 14866109
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline].
    FISCHER R; GEORGI F; WEBER R
    Schweiz Med Wochenschr; 1951 Aug; 81(34):817-9; contd. PubMed ID: 14866104
    [No Abstract]   [Full Text] [Related]  

  • 11. On the antagonism of ergot alkaloids and dopamine by phenothiazines.
    Stone TW
    Experientia; 1974 Jul; 30(7):827-9. PubMed ID: 4847689
    [No Abstract]   [Full Text] [Related]  

  • 12. Ergot and its alkaloids.
    Schiff PL
    Am J Pharm Educ; 2006 Oct; 70(5):98. PubMed ID: 17149427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with the use of alkanolamides of lysergic acid in clinical obstetrics].
    WOLLMANN H
    Z Geburtshilfe Gynakol; 1950; 134(1):109-23. PubMed ID: 14810077
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosynthesis of ergot alkaloids in Claviceps paspali. 3. Incorporation of 6-methyl-delta-8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H.
    Agurell S
    Acta Pharm Suec; 1966 Apr; 3(2):65-70. PubMed ID: 5946518
    [No Abstract]   [Full Text] [Related]  

  • 15. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of effects of lysergic acid diethylamide (LSD).
    SALVATORE S; HYDE RW
    AMA Arch Neurol Psychiatry; 1956 Jul; 76(1):50-9. PubMed ID: 13338909
    [No Abstract]   [Full Text] [Related]  

  • 17. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
    CURTIS DR
    Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25).
    JARVIK ME; ABRAMSON HA; HIRSCH MW
    J Abnorm Psychol; 1955 Nov; 51(3):657-62. PubMed ID: 13286016
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 20. INCREASE IN ANTI-5HT ACTIVITY BY L-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS.
    YUI T; TAKEO Y
    Jpn J Pharmacol; 1964 Mar; 14():107-8. PubMed ID: 14167727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.